Skip to content

PROKIDNEY CORP CLASS A (PROK) — insider trading

Health Care · NASDAQ

PROKIDNEY CORP CLASS A (PROK) has 27 reported SEC Form 4 insider transactions in our data, including 6 open-market sales among the most recent 27 (latest 2026-08-20).

Recent Form 4 transactions

DateInsiderRoleTypeSharesPriceValueFiling
2026-08-20 Pereira Brian JG Director Open-market sale 27,052 $1.42 $38.4K Form 4
2026-08-20 Pereira Brian JG Director Open-market sale 222,948 $1.42 $316.6K Form 4
2026-08-19 Pereira Brian JG Director Open-market sale 27,051 $1.44 $39.0K Form 4
2026-08-19 Pereira Brian JG Director Open-market sale 222,949 $1.44 $321.2K Form 4
2026-08-18 Pereira Brian JG Director Open-market sale 27,826 $1.37 $38.2K Form 4
2026-08-18 Pereira Brian JG Director Open-market sale 229,338 $1.37 $314.5K Form 4
2026-08-04 Pereira Brian JG Director Conversion of derivative (derivative) 675,235 — $0 Form 4
2026-08-04 Pereira Brian JG Director Conversion of derivative (derivative) 675,235 — $0 Form 4
2026-08-04 Pereira Brian JG Director Conversion of derivative (derivative) 81,929 — $0 Form 4
2026-08-04 Pereira Brian JG Director Conversion of derivative (derivative) 81,929 — $0 Form 4
2026-08-04 Pereira Brian JG Director Conversion of derivative 675,235 — $0 Form 4
2026-08-04 Pereira Brian JG Director Conversion of derivative 81,929 — $0 Form 4
2026-07-01 Locke Kenneth Thomas Officer (Chief Technical Officer) Grant / award / vesting (derivative) 750,000 — $0 Form 4
2026-06-12 Girolamo Todd C Officer (Chief Legal Officer) Conversion of derivative (derivative) 163,857 — $0 Form 4
2026-06-12 Girolamo Todd C Officer (Chief Legal Officer) Conversion of derivative (derivative) 163,857 — $0 Form 4
2026-06-12 Girolamo Todd C Officer (Chief Legal Officer) Conversion of derivative 163,857 — $0 Form 4
2026-05-28 Pereira Brian JG Director Grant / award / vesting (derivative) 135,000 — $0 Form 4
2026-05-28 Legorreta Pablo G. Director, 10% owner Grant / award / vesting (derivative) 135,000 — $0 Form 4
2026-05-28 Sinha Uma Director Grant / award / vesting (derivative) 135,000 — $0 Form 4
2026-05-28 DOYLE WILLIAM F Director Grant / award / vesting (derivative) 135,000 — $0 Form 4
2026-05-28 Fox Jennifer A. Director Grant / award / vesting (derivative) 135,000 — $0 Form 4
2026-05-28 Jimenez Santos Jose Ignacio Director Grant / award / vesting (derivative) 135,000 — $0 Form 4
2026-05-28 Lotvin Alan Director Grant / award / vesting (derivative) 135,000 — $0 Form 4
2026-04-28 Control Empresarial de Capitales S.A. de C.V. 10% owner, Other Conversion of derivative (derivative) 63,118,645 — $0 Form 4
2026-04-28 Control Empresarial de Capitales S.A. de C.V. 10% owner, Other Conversion of derivative (derivative) 63,118,645 — $0 Form 4
2026-04-28 Control Empresarial de Capitales S.A. de C.V. 10% owner, Other Conversion of derivative 63,118,645 — $0 Form 4
2026-03-01 Coulston James Officer (Chief Financial Officer) Grant / award / vesting (derivative) 600,000 — $0 Form 4

Ask the chat about PROK's insider activity →

Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.

Source: SEC EDGAR Form 3/4/5. See the full company profile: PROKIDNEY CORP CLASS A (PROK).

Last updated 2026-08-20 (most recent filing date).

Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.